Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jovanovic

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
British Journal of Haematology|April 22, 2008
Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyAndrew M Evens, Paul T Schumacker, Irene B Helenowski, et al.
Clinical and Translational Science|September 13, 2014
Assessing statistical competencies in clinical and translational science education: one size does not fit allRobert A Oster, Christopher J Lindsell, Leah J Welty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2003
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancerChris H Takimoto, Kira Glover, Xiaoke Huang, et al.
Oral Oncology|July 13, 2013
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakiaStuart J Wong, Bruce Campbell, Becky Massey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trialAndrew M Evens, William G Spies, Irene B Helenowski, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|April 12, 2017
Risk Factors for Intraoperative Hypertension during Surgery for Primary HyperparathyroidismVera D Sabljak, Vladan R Zivaljevic, Biljana R Milicic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2010
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsA M Evens, B D Jovanovic, Y-C Su, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 7, 2012
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trialSeema A Khan, Robert T Chatterton, Nancy Michel, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
British Journal of Haematology|April 22, 2008
Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin familyAndrew M Evens, Paul T Schumacker, Irene B Helenowski, et al.
Clinical and Translational Science|September 13, 2014
Assessing statistical competencies in clinical and translational science education: one size does not fit allRobert A Oster, Christopher J Lindsell, Leah J Welty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2003
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancerChris H Takimoto, Kira Glover, Xiaoke Huang, et al.
Oral Oncology|July 13, 2013
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakiaStuart J Wong, Bruce Campbell, Becky Massey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trialAndrew M Evens, William G Spies, Irene B Helenowski, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|April 12, 2017
Risk Factors for Intraoperative Hypertension during Surgery for Primary HyperparathyroidismVera D Sabljak, Vladan R Zivaljevic, Biljana R Milicic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2010
Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsA M Evens, B D Jovanovic, Y-C Su, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 7, 2012
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trialSeema A Khan, Robert T Chatterton, Nancy Michel, et al.
Pageof 14